An Australian Narrative Review of Adoptive Cellular Therapies in Malignancy: Expanding Indications, Referral Pathways and Safety Beyond Specialist Centres. [PDF]
Childs S +15 more
europepmc +1 more source
Association of Ferritin Levels With Cytokine Release Syndrome in CAR T-Cell Therapy: A Systematic Review and Meta-Analysis. [PDF]
Sah R +6 more
europepmc +1 more source
Artificial intelligence-enabled nursing surveillance for pediatric cancer immunotherapy: integrating biomarkers, patient-reported outcomes, and long-term toxicity management. [PDF]
Peng Y +5 more
europepmc +1 more source
Safety Signals of CRS and ICANS With Tarlatamab in Relapsed Small Cell Lung Cancer: Insights From a Small Case Study. [PDF]
Choi J, Lee S, Lee SY.
europepmc +1 more source
Practical Recommendations for Implementing Remote Patient Monitoring for Patients Receiving Bispecific Antibodies for Multiple Myeloma. [PDF]
Varga C, Schaefer E.
europepmc +1 more source
Elranatamab in relapsed/refractory multiple myeloma patients on hemodialysis: A real-world case series. [PDF]
Batgi H +5 more
europepmc +1 more source
A review on toxicities of T-cell engager-based therapies in solid tumors. [PDF]
Bastien E +5 more
europepmc +1 more source
Recognition and management of early complications in CAR-T cell therapy and virus-specific T-lymphocyte therapy: a practical clinical reference. [PDF]
Ussowicz M +3 more
europepmc +1 more source
Immunobiology and Immune-Related Toxicities of Cancer Immunotherapy: Organ-Specific Immune-Related Adverse Events, Cytokine Release Syndrome, and Immune Effector Cell-Associated Neurotoxicity Syndrome. [PDF]
Kim S +8 more
europepmc +1 more source

